The future of cryoablation: An abscopal effect.

Area of Science:

• Immunology
• Oncology
• Surgical Oncology

Background:

• Cryoablation is a widely used cancer treatment for solid tumors and soft tissues.
• The abscopal effect, an immune response distant from the treated tumor, is a key area for future cryoablation research.
• Cryoablation can stimulate an immune response, either alone or in combination with other therapies.

Purpose of the Study:

• To review the immune response triggered by cryoablation.
• To discuss the combination of cryoablation with various immunotherapies.
• To explore novel strategies for enhancing cryoablation's efficacy.

Main Methods:

• Review of existing literature on cryoablation and immunotherapy.
• Analysis of cryoablation's effects on immune cells and tumor microenvironment.
• Discussion of potential combination therapies including chemotherapy, cell therapy, and molecular agents.

Main Results:

• Cryoablation alone can increase immune response.
• Combining cryoablation with immunotherapies like cyclophosphamide, NK cells, GM-CSF, CTLA-4, and PD-1 inhibitors can enhance anti-tumor immunity.
• Hydrogen gas molecules may improve mitochondrial function in T cells, potentially rescuing exhausted CD8+ T cells.

Conclusions:

• Improving cryoablative techniques to maximize necrosis and minimize apoptosis is crucial.
• Combining cryoablation with immunotherapies holds significant promise for improving treatment outcomes.
• Novel combinations, such as with hydrogen gas, may offer new avenues for enhancing patient survival in advanced cancers.